Ameliorative effect of quercetin on the destruction caused by experimental periodontitis in rats

J Periodontal Res. 2010 Dec;45(6):788-95. doi: 10.1111/j.1600-0765.2010.01301.x.

Abstract

Background and objective: The purpose of this study was to evaluate the effect of quercetin, a flavonol that exhibits anti-inflammatory properties, on experimental periodontal destruction in rats.

Material and methods: Osteoclast formation on maxillary palatal alveolus was induced with daily lipopolysaccharide (LPS) injections (0, 1 or 5 mg/mL) for 3 d. Five days later, the osteoclasts on bony surfaces were counted after histochemical staining for tartrate-resistant acid phosphatase. The effect of intragastric quercetin on the osteoclast formation was evaluated in the following three groups: quercetin (75 mg/kg/d by oral feeding); LPS (5 mg/mL); and quercetin plus LPS. Moreover, the effect of quercetin on the ligature-induced periodontitis around maxillary second and mandibular first molars was further evaluated by microcomputerized tomography (on days 0, 4, 8 and 12) and by histometry (on day 8).

Results: A dose-dependent increase in osteoclasts occurred after LPS injections. However, quercetin (75 mg/kg) reduced the 5 mg/mL LPS-induced osteoclasts. Using microcomputerized tomography, the bone crest levels at ligation sites were found to be significantly more apical than at the control sites on days 8 and 12; however, the apically located bone crests rebounded in rats from the quercetin-plus-ligation group. Histometry demonstrated significantly more coronal alveolar crest bone levels, less inflammatory cell-infiltrated connective tissue areas and less connective tissue attachments in the ligation-plus-quercetin group compared with those in the ligation group.

Conclusion: As the quercetin could reduce the LPS-induced osteoclast formation and the ligature-enhanced periodontal inflammation and bone loss, we suggest that it may have an ameliorative effect on periodontal destruction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Alveolar Bone Loss / diagnostic imaging
  • Alveolar Bone Loss / drug therapy*
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Dose-Response Relationship, Drug
  • Ligation
  • Lipopolysaccharides
  • Male
  • Osteoclasts / drug effects
  • Periodontitis / drug therapy*
  • Quercetin / administration & dosage
  • Quercetin / therapeutic use*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • X-Ray Microtomography

Substances

  • Antioxidants
  • Lipopolysaccharides
  • Quercetin